A prime example is HPV-driven cervical SCC (squamous cell carcinoma), where cancer cells upregulate anti-ferroptosis pathways through mechanisms such as the aforementioned p53 degradation and Nrf2 activation, enabling them to survive under pressures that would normally trigger ferroptotic clearance. Here, TP53 is linked to cancer.